PD
TARS icon

Point72 (DIFC)’s Tarsus Pharmaceuticals TARS Stock Holding History

Point72 (DIFC)’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$218K Buy
+3,663
New +$180K 0.01% 426

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Point72 (DIFC)'s TARS Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2025: 3,663 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #426 among its holdings.

220 funds tracked by Wall St. Rank hold TARS as of Q3 2025.

  • Point72 (DIFC) held 3,663 shares of Tarsus Pharmaceuticals worth $218K as of Q3 2025.
  • Tarsus Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • Tarsus Pharmaceuticals made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #426 holding.
  • 220 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.